Almesh Kadakol

478 total citations
15 papers, 407 citations indexed

About

Almesh Kadakol is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Almesh Kadakol has authored 15 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Almesh Kadakol's work include Natural Antidiabetic Agents Studies (3 papers), Renin-Angiotensin System Studies (3 papers) and Epigenetics and DNA Methylation (2 papers). Almesh Kadakol is often cited by papers focused on Natural Antidiabetic Agents Studies (3 papers), Renin-Angiotensin System Studies (3 papers) and Epigenetics and DNA Methylation (2 papers). Almesh Kadakol collaborates with scholars based in India. Almesh Kadakol's co-authors include Anil Bhanudas Gaikwad, Santosh Kumar Goru, Vajir Malek, Anuradha Pandey, Nisha Sharma, Yogesh A. Kulkarni, P. Shalem Raj, Parveen Kumar, Vinayak Jamdade and Nitin Mundhe and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and British Journal of Pharmacology.

In The Last Decade

Almesh Kadakol

15 papers receiving 404 citations

Peers

Almesh Kadakol
Santosh Kumar Goru India
Ursula Schmid Germany
Gema Marín‐Royo Spain
Derek Y.C. Yuen Australia
Takashi Naito Japan
Yilan Shen China
Zeyuan Lin China
Kumiko Ohta Japan
Santosh Kumar Goru India
Almesh Kadakol
Citations per year, relative to Almesh Kadakol Almesh Kadakol (= 1×) peers Santosh Kumar Goru

Countries citing papers authored by Almesh Kadakol

Since Specialization
Citations

This map shows the geographic impact of Almesh Kadakol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Almesh Kadakol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Almesh Kadakol more than expected).

Fields of papers citing papers by Almesh Kadakol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Almesh Kadakol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Almesh Kadakol. The network helps show where Almesh Kadakol may publish in the future.

Co-authorship network of co-authors of Almesh Kadakol

This figure shows the co-authorship network connecting the top 25 collaborators of Almesh Kadakol. A scholar is included among the top collaborators of Almesh Kadakol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Almesh Kadakol. Almesh Kadakol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Goru, Santosh Kumar, Almesh Kadakol, & Anil Bhanudas Gaikwad. (2017). Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy. Pharmacological Research. 120. 170–179. 25 indexed citations
2.
Kadakol, Almesh, Santosh Kumar Goru, Vajir Malek, & Anil Bhanudas Gaikwad. (2017). Esculetin ameliorates vascular perturbation by intervening in the occupancy of H2BK120Ub at At1, At2, Tgfβ1 and Mcp1 promoter gene in thoracic aorta of IR and T2D rats. Biomedicine & Pharmacotherapy. 95. 1461–1468. 12 indexed citations
3.
Kadakol, Almesh, et al.. (2017). Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications. Indian Journal of Pharmacology. 49(5). 348–348. 15 indexed citations
4.
Goru, Santosh Kumar, Almesh Kadakol, Vajir Malek, et al.. (2017). Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes. British Journal of Pharmacology. 174(18). 3118–3130. 65 indexed citations
5.
Pandey, Anuradha, P. Shalem Raj, Santosh Kumar Goru, et al.. (2017). Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway. Pharmacological Reports. 69(4). 666–672. 32 indexed citations
6.
Kadakol, Almesh, Vajir Malek, Santosh Kumar Goru, et al.. (2017). Esculetin ameliorates insulin resistance and type 2 diabetic nephropathy through reversal of histone H3 acetylation and H2A lysine 119 monoubiquitination. Journal of Functional Foods. 35. 256–266. 19 indexed citations
7.
Pandey, Anuradha, Santosh Kumar Goru, Almesh Kadakol, et al.. (2016). H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats. Biochimie. 131. 68–76. 21 indexed citations
8.
Goru, Santosh Kumar, Almesh Kadakol, Anuradha Pandey, et al.. (2016). Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis. Biochemical Journal. 473(21). 3937–3949. 37 indexed citations
9.
Kadakol, Almesh, Nisha Sharma, Yogesh A. Kulkarni, & Anil Bhanudas Gaikwad. (2016). Esculetin: A phytochemical endeavor fortifying effect against non-communicable diseases. Biomedicine & Pharmacotherapy. 84. 1442–1448. 30 indexed citations
10.
Pandey, Anuradha, et al.. (2016). FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?. Current Diabetes Reviews. 12(3). 223–230. 20 indexed citations
11.
Kadakol, Almesh, et al.. (2015). Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia. Biochemical and Biophysical Research Communications. 461(2). 342–347. 34 indexed citations
12.
Kadakol, Almesh, Anuradha Pandey, Santosh Kumar Goru, Vajir Malek, & Anil Bhanudas Gaikwad. (2015). Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis. European Journal of Pharmacology. 765. 591–597. 13 indexed citations
13.
Kumar, Parveen, Almesh Kadakol, Nitin Mundhe, et al.. (2015). Curcumin as an Adjuvant to Breast Cancer Treatment. Anti-Cancer Agents in Medicinal Chemistry. 15(5). 647–656. 30 indexed citations
14.
Pandey, Anuradha, Santosh Kumar Goru, Almesh Kadakol, Vajir Malek, & Anil Bhanudas Gaikwad. (2015). Differential regulation of angiotensin converting enzyme 2 and nuclear factor-κB by angiotensin II receptor subtypes in type 2 diabetic kidney. Biochimie. 118. 71–81. 28 indexed citations
15.
Kadakol, Almesh, Vajir Malek, Santosh Kumar Goru, Anuradha Pandey, & Anil Bhanudas Gaikwad. (2015). Esculetin reverses histone H2A/H2B ubiquitination, H3 dimethylation, acetylation and phosphorylation in preventing type 2 diabetic cardiomyopathy. Journal of Functional Foods. 17. 127–136. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Santosh Kumar Goru Breakdown of academic impact, for papers by Ursula Schmid Breakdown of academic impact, for papers by Gema Marín‐Royo Breakdown of academic impact, for papers by Derek Y.C. Yuen Breakdown of academic impact, for papers by Takashi Naito Breakdown of academic impact, for papers by Yilan Shen Breakdown of academic impact, for papers by Zeyuan Lin Breakdown of academic impact, for papers by Kumiko Ohta
Rankless by CCL
2026